Cho-A Pharmaceutical Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
43,913
43,087
50,120
55,551
58,865
Cost of Goods Sold (COGS) incl. D&A
20,946
22,940
26,216
29,422
31,138
Gross Income
22,967
20,147
23,905
26,128
27,727
SG&A Expense
21,999
24,529
23,972
26,181
27,301
Unusual Expense
11
169
42
172
553
Non Operating Income/Expense
609
569
909
564
303
Interest Expense
344
530
527
492
546
Pretax Income
1,634
4,174
568
113
754
Income Tax
32
43
365
35
623
Equity in Affiliates
93
95
11
34
-
Consolidated Net Income
1,758
4,122
943
114
1,377
Net Income
1,804
4,075
1,012
163
1,624
Net Income After Extraordinaries
1,804
4,075
1,012
163
1,624
Net Income Available to Common
1,804
4,075
1,012
163
1,624
EPS (Basic)
64.00
144.00
36.00
6.00
57.00
Basic Shares Outstanding
28
28
28
28
28
EPS (Diluted)
63.73
143.95
35.75
5.76
53.33
Diluted Shares Outstanding
28
28
28
28
29
EBITDA
2,392
2,770
1,824
1,791
2,418
Non-Operating Interest Income
389
337
295
266
180
Minority Interest Expense
46
46
69
49
247
Equity in Affiliates (Pretax)
-
-
-
-
162
About Cho-A Pharmaceutical Co.
View Profile
